Buy Sun Pharma; Sobha may test Rs 450: Ashwani Gujral

Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "Since we are talking of a bit medium term, I think the way real estate has broken out as a sector and Sobha as a stock, I think over the next few weeks it could move towards levels of Rs 450.""Similarly, Sun Pharmaceutical Industries around Rs 680-700 has found consistent support. So, for longer term investors this is a good place to buy. Probably in a better news environment, you will see Rs 900 coming pretty soon," he said."Coal India is standing at the door of its 200-day moving average. So, chances are even that stock is kind of bottoming out given commodities are stabilising a bit. So, out there you could see levels of about Rs 400 in the weeks to come."